Using Claims Data to Assess Treatment Quality of First-Episode Psychosis
Objective:Coordinated specialty care (CSC) has become the standard of care for first-episode psychosis (FEP). The gap between CSC best practices and the actual care delivered is unknown. This longitudinal study aimed to measure that gap by using a large Medicaid claims database and 10 quality indica...
Saved in:
Published in: | Psychiatric services (Washington, D.C.) Vol. 72; no. 3; pp. 247 - 253 |
---|---|
Main Authors: | , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
American Psychiatric Association
01-03-2021
American Psychiatric Publishing, Inc |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Objective:Coordinated specialty care (CSC) has become the standard of care for first-episode psychosis (FEP). The gap between CSC best practices and the actual care delivered is unknown. This longitudinal study aimed to measure that gap by using a large Medicaid claims database and 10 quality indicators (QIs) reflecting aspects of CSC and to study the relationship between these QIs and future health care utilization.Methods:Individuals with FEP were identified in a Missouri Medicaid claims database. Participants were required to have been eligible for Medicaid benefits for at least 10 months in the year prior to and the year after their first episode of psychosis and to have had no evidence of a prior psychosis diagnosis. Descriptive statistics were generated for each of the QIs, and a stratified Cox regression was used to identify predictors of subsequent health care utilization.Results:Data were obtained for 6,246 participants, and follow-up lasted a mean of 4.24 years. Significant practice gaps were found in the use and monitoring of antipsychotic medications. Of those prescribed antipsychotic medication, 5% received prescriptions above recommended daily doses, 16% received two or more antipsychotics, and 20% were treated with olanzapine or clozapine. Among the QIs, lack of monitoring for smoking (hazard ratio [HR]=2.71, 95% confidence interval [CI]=2.47–2.97) and lack of integrated care delivery in treatment (HR=2.00, 95% CI=1.92–2.08) were most associated with psychiatric hospitalization.Conclusions:In most cases, treatment was far from meeting CSC recommendations, suggesting that implementation of CSC requires substantial modifications to delivery of care for individuals with FEP. |
---|---|
AbstractList | Coordinated specialty care (CSC) has become the standard of care for first-episode psychosis (FEP). The gap between CSC best practices and the actual care delivered is unknown. This longitudinal study aimed to measure that gap by using a large Medicaid claims database and 10 quality indicators (QIs) reflecting aspects of CSC and to study the relationship between these QIs and future health care utilization.
Individuals with FEP were identified in a Missouri Medicaid claims database. Participants were required to have been eligible for Medicaid benefits for at least 10 months in the year prior to and the year after their first episode of psychosis and to have had no evidence of a prior psychosis diagnosis. Descriptive statistics were generated for each of the QIs, and a stratified Cox regression was used to identify predictors of subsequent health care utilization.
Data were obtained for 6,246 participants, and follow-up lasted a mean of 4.24 years. Significant practice gaps were found in the use and monitoring of antipsychotic medications. Of those prescribed antipsychotic medication, 5% received prescriptions above recommended daily doses, 16% received two or more antipsychotics, and 20% were treated with olanzapine or clozapine. Among the QIs, lack of monitoring for smoking (hazard ratio [HR]=2.71, 95% confidence interval [CI]=2.47-2.97) and lack of integrated care delivery in treatment (HR=2.00, 95% CI=1.92-2.08) were most associated with psychiatric hospitalization.
In most cases, treatment was far from meeting CSC recommendations, suggesting that implementation of CSC requires substantial modifications to delivery of care for individuals with FEP. OBJECTIVECoordinated specialty care (CSC) has become the standard of care for first-episode psychosis (FEP). The gap between CSC best practices and the actual care delivered is unknown. This longitudinal study aimed to measure that gap by using a large Medicaid claims database and 10 quality indicators (QIs) reflecting aspects of CSC and to study the relationship between these QIs and future health care utilization. METHODSIndividuals with FEP were identified in a Missouri Medicaid claims database. Participants were required to have been eligible for Medicaid benefits for at least 10 months in the year prior to and the year after their first episode of psychosis and to have had no evidence of a prior psychosis diagnosis. Descriptive statistics were generated for each of the QIs, and a stratified Cox regression was used to identify predictors of subsequent health care utilization. RESULTSData were obtained for 6,246 participants, and follow-up lasted a mean of 4.24 years. Significant practice gaps were found in the use and monitoring of antipsychotic medications. Of those prescribed antipsychotic medication, 5% received prescriptions above recommended daily doses, 16% received two or more antipsychotics, and 20% were treated with olanzapine or clozapine. Among the QIs, lack of monitoring for smoking (hazard ratio [HR]=2.71, 95% confidence interval [CI]=2.47-2.97) and lack of integrated care delivery in treatment (HR=2.00, 95% CI=1.92-2.08) were most associated with psychiatric hospitalization. CONCLUSIONSIn most cases, treatment was far from meeting CSC recommendations, suggesting that implementation of CSC requires substantial modifications to delivery of care for individuals with FEP. Objective: Coordinated specialty care (CSC) has become the standard of care for first-episode psychosis (FEP). The gap between CSC best practices and the actual care delivered is unknown. This longitudinal study aimed to measure that gap by using a large Medicaid claims database and 10 quality indicators (QIs) reflecting aspects of CSC and to study the relationship between these QIs and future health care utilization. Methods: Individuals with FEP were identified in a Missouri Medicaid claims database. Participants were required to have been eligible for Medicaid benefits for at least 10 months in the year prior to and the year after their first episode of psychosis and to have had no evidence of a prior psychosis diagnosis. Descriptive statistics were generated for each of the QIs, and a stratified Cox regression was used to identify predictors of subsequent health care utilization. Results: Data were obtained for 6,246 participants, and follow-up lasted a mean of 4.24 years. Significant practice gaps were found in the use and monitoring of antipsychotic medications. Of those prescribed antipsychotic medication, 5% received prescriptions above recommended daily doses, 16% received two or more antipsychotics, and 20% were treated with olanzapine or clozapine. Among the QIs, lack of monitoring for smoking (hazard ratio [HR]=2.71, 95% confidence interval [CI]=2.47–2.97) and lack of integrated care delivery in treatment (HR=2.00, 95% CI=1.92–2.08) were most associated with psychiatric hospitalization. Conclusions: In most cases, treatment was far from meeting CSC recommendations, suggesting that implementation of CSC requires substantial modifications to delivery of care for individuals with FEP. |
Author | Ren, Yingqian Rubio, Jose M Wright, Abel Reist, Christopher Valdes, Elise |
Author_xml | – sequence: 1 givenname: Christopher surname: Reist fullname: Reist, Christopher email: creist@uci.edu – sequence: 2 givenname: Elise surname: Valdes fullname: Valdes, Elise email: creist@uci.edu – sequence: 3 givenname: Yingqian surname: Ren fullname: Ren, Yingqian email: creist@uci.edu – sequence: 4 givenname: Abel surname: Wright fullname: Wright, Abel email: creist@uci.edu – sequence: 5 givenname: Jose M surname: Rubio fullname: Rubio, Jose M email: creist@uci.edu |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33167819$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kD1PwzAQhi0EgvLxA1iQJRaWlHMcf2SsCgWkSoDUzpHjOOAqiUMuGfrvCRQ6IDHdDc_z3uk9JYdNaBwhlwymjCl5a9rWT1ucxsBSAJGKAzJhQqgoVQCH4w5KRLHicEJOETcAwBSTx-SEcyaVZumEPK7RN290XhlfI70zvaF9oDNEh0hXnTN97Zqevg6m8v2WhpIufId9dN96DIWjL7i17wE9npOj0lToLn7mGVkv7lfzx2j5_PA0ny0jw6XuI6YLC0InIkl4zrV0PLextqUB0GkhOHOljAuuc8t0LEtu5TjBicI6ASY3_Izc7HLbLnwMDvus9mhdVZnGhQGzOBEpT2QKfESv_6CbMHTN-F0WC8a4UlomI8V2lO0CYufKrO18bbptxiD7qjn7qjlrR-m35tG5-kke8toVe-O31xGY7oBvd3_2_8RPIRSJGw |
CitedBy_id | crossref_primary_10_1176_appi_ps_72305 crossref_primary_10_1002_pcn5_13 crossref_primary_10_7759_cureus_39488 crossref_primary_10_1016_j_biopsych_2024_06_026 crossref_primary_10_1176_appi_ps_202100133 |
Cites_doi | 10.1176/appi.ajp.2011.10081224 10.1176/appi.ps.201300001 10.1093/schbul/sbp129 10.4088/JCP.10m06497 10.2337/diacare.27.2.596 10.1016/j.psychres.2018.04.002 10.1093/oxfordjournals.schbul.a033303 10.1001/jamapsychiatry.2016.0538 10.1001/jamapsychiatry.2018.0623 10.1176/appi.ajp.2014.13101355 10.1192/bjp.bp.109.074526 10.1176/appi.ajp.2015.15050632 10.1001/archpsyc.56.3.241 10.4088/JCP.14m09289 10.1016/j.eurpsy.2005.05.015 10.1093/schbul/sbv224 10.1016/j.schres.2015.11.016 10.1176/appi.ajp.2018.17091001 10.1093/schbul/sbp116 10.1176/appi.ps.201400413 10.1001/jamapsychiatry.2015.0270 10.1097/NMD.0b013e31818ee231 10.1001/jama.282.15.1458 10.1056/NEJMoa1203241 10.1001/jamapsychiatry.2017.1322 10.1093/schbul/sbn138 |
ContentType | Journal Article |
Copyright | Copyright © 2021 by the American Psychiatric Association 2021 Copyright American Psychiatric Publishing, Inc. Mar 2021 |
Copyright_xml | – notice: Copyright © 2021 by the American Psychiatric Association 2021 – notice: Copyright American Psychiatric Publishing, Inc. Mar 2021 |
DBID | NPM AAYXX CITATION K9. NAPCQ 7X8 |
DOI | 10.1176/appi.ps.201900595 |
DatabaseName | PubMed CrossRef ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
DatabaseTitle | PubMed CrossRef ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic ProQuest Health & Medical Complete (Alumni) |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Public Health |
EISSN | 1557-9700 |
EndPage | 253 |
ExternalDocumentID | 10_1176_appi_ps_201900595 33167819 10.1176/appi.ps.201900595 |
Genre | Journal Article |
GroupedDBID | - 123 1AW 1HT 1QT 29P 5RE 85S AAPBV AAWTL ABFLS ABIVO ACHQT ACNCT ACVYA ADACO ADBBV AENEX AHMBA ALMA_UNASSIGNED_HOLDINGS B-7 BAJDF BAWUL CS3 DIK DU5 E3Z EBS F5P FH7 G0H HZ H~9 O0- P2P PQEST PQQKQ RAY RYA SJN TWZ UHB WOQ X X4V XHC XZL YZZ ZA5 --- -~X ..I 18M 2WC 4.4 8R4 8R5 AAIKC AAMNW AAWTO ACGFO AGHSJ EX3 GX1 H13 HZ~ NPM OK1 OMB OMG PCD Q2X TR2 USG V62 VVN W8F WOW XSW YSK Z0I ZVN AAYXX CITATION K9. NAPCQ 7X8 |
ID | FETCH-LOGICAL-a368t-18dc05845443b386e3bc28cfa0089d531ef62d38bc1826f3c61820e5dce50aba3 |
ISSN | 1075-2730 |
IngestDate | Fri Aug 16 21:53:59 EDT 2024 Fri Nov 22 18:37:51 EST 2024 Wed Nov 20 13:33:38 EST 2024 Sat Sep 28 08:35:13 EDT 2024 Mon Mar 01 05:13:58 EST 2021 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | treatment psychoses treatment guidelines first episode psychosis population health quality |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-a368t-18dc05845443b386e3bc28cfa0089d531ef62d38bc1826f3c61820e5dce50aba3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 33167819 |
PQID | 2511377864 |
PQPubID | 41485 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_2459346903 proquest_journals_2511377864 crossref_primary_10_1176_appi_ps_201900595 pubmed_primary_33167819 appi_journals_10_1176_appi_ps_201900595 |
ProviderPackageCode | RAY RYA X4V 1QT BAJDF G0H |
PublicationCentury | 2000 |
PublicationDate | 20210301 2021-Mar-01 2021-03-01 |
PublicationDateYYYYMMDD | 2021-03-01 |
PublicationDate_xml | – month: 03 year: 2021 text: 20210301 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Arlington |
PublicationTitle | Psychiatric services (Washington, D.C.) |
PublicationTitleAlternate | Psychiatr Serv |
PublicationYear | 2021 |
Publisher | American Psychiatric Association American Psychiatric Publishing, Inc |
Publisher_xml | – name: American Psychiatric Association – name: American Psychiatric Publishing, Inc |
References | Alvir, JMJ 1999; 56 Niv, N 2010; 36 Penn, DL 2015; 66 Kelly, DL 2010; 36 Cabana, MD 1999; 282 Schooler, NR 2016; 173 Parker, AG 2011; 37 Tanskanen, A 2018; 175 Susser, E 2020; 46 Alvarez-Jiménez, M 2011; 37 Marcy, P 2015; 76 Addington, J 2015; 66 Robinson, DG 2015; 172 John, M 2015; 172 Taipale, H 2018; 175 Premkumar, P 2010; 197 Rand, CS 1999; 282 Kane, JM 2015; 76 Colizzi, M 2016; 170 Schooler, NR 2015; 172 Mittendorfer-Rutz, E 2017; 74 Subotnik, KL 2015; 72 Leslie, D 2016; 42 Majak, M 2017; 74 Haukka, J 2011; 168 Caffery, E 2014; 65 Campagna, EJ 2016; 73 Ni, Q 2012; 73 Leclerc, C 2009; 196 Casaus, LR 2015; 72 Tiihonen, J 2011; 168 Robinson, DG 2016; 173 Mueser, KT 2015; 66 Barrett, A 2014; 65 Patel, U 2012; 73 Carra, E 2016; 170 Sint, K 2016; 42 Kendall, T 2010; 197 Powe, NR 1999; 282 Young, AS 2010; 36 Kouvaras, S 2018; 264 Kelly, BD 2006; 21 Zetterqvist, J 2012; 367 Nterian, Z 2018; 264 van der Ven, E 2020; 46 Rosenheck, R 2016; 42 Lecomte, T 2009; 196 Cohen, AN 2010; 36 Halldner, L 2012; 367 Woerner, MG 1999; 56 Galling, B 2018; 75 Buchanan, RW 2010; 36 Hickling, LM 2018; 264 Berkowitz, RL 2012; 73 Clarke, M 2006; 21 Lichtenstein, P 2012; 367 Morrato, EH 2016; 73 Bird, V 2010; 197 Taylor, M 2011; 168 Kreyenbuhl, J 2010; 36 Hetrick, SE 2011; 37 Kane, JM 2016; 173 Gilmer, TP 2020; 46 Brown, JD 2014; 65 Tiihonen, J 2018; 175 Corbiere, M 2009; 196 Steinwachs, DM 1998; 24 Pawar, A 2018; 75 Brewer, SE 2016; 73 Fraietta, S 2016; 170 Correll, CU 2018; 75 Kamali, M 2006; 21 Tiihonen, J 2017; 74 Robinson, D 1999; 56 Ventura, J 2015; 72 Lehman, AF 1998; 24 Schooler, NR 2015; 76 B20 B21 B22 B23 B24 B25 B26 B27 B28 Gilmer TP (B11) 2020; 46 B10 B12 B13 B14 B15 B16 B17 B18 B19 B1 B2 B3 B4 B5 B6 B7 B8 B9 |
References_xml | – volume: 46 start-page: 91 year: 2020 end-page: 97 article-title: Service use following first-episode schizophrenia among commercially insured youth publication-title: Schizophr Bull contributor: fullname: Gilmer, TP – volume: 168 start-page: 603 year: 2011 end-page: 609 article-title: A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia publication-title: Am J Psychiatry contributor: fullname: Haukka, J – volume: 56 start-page: 241 year: 1999 end-page: 247 article-title: Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder publication-title: Arch Gen Psychiatry contributor: fullname: Alvir, JMJ – volume: 65 start-page: 121 year: 2014 end-page: 124 article-title: State and demographic variation in use of depot antipsychotics by Medicaid beneficiaries with schizophrenia publication-title: Psychiatr Serv contributor: fullname: Brown, JD – volume: 36 start-page: 732 year: 2010 end-page: 739 article-title: The appropriateness of routine medication treatment for schizophrenia publication-title: Schizophr Bull contributor: fullname: Young, AS – volume: 282 start-page: 1458 year: 1999 end-page: 1465 article-title: Why don’t physicians follow clinical practice guidelines? A framework for improvement publication-title: JAMA contributor: fullname: Cabana, MD – volume: 282 start-page: 1458 year: 1999 end-page: 1465 article-title: Why don’t physicians follow clinical practice guidelines? A framework for improvement publication-title: JAMA contributor: fullname: Powe, NR – volume: 73 start-page: 498 year: 2012 end-page: 503 article-title: The impact of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) on prescribing practices: an analysis of data from a large midwestern state publication-title: J Clin Psychiatry contributor: fullname: Ni, Q – volume: 264 start-page: 151 year: 2018 end-page: 154 article-title: Non-adherence to antipsychotic medication in first-episode psychosis patients publication-title: Psychiatry Res contributor: fullname: Kouvaras, S – volume: 170 start-page: 311 year: 2016 end-page: 317 article-title: Substance use, medication adherence and outcome one year following a first episode of psychosis publication-title: Schizophr Res contributor: fullname: Carra, E – volume: 37 start-page: 619 year: 2011 end-page: 630 article-title: Preventing the second episode: a systematic review and meta-analysis of psychosocial and pharmacological trials in first-episode psychosis publication-title: Schizophr Bull contributor: fullname: Hetrick, SE – volume: 175 start-page: 765 year: 2018 end-page: 773 article-title: 20-year nationwide follow-up study on discontinuation of antipsychotic treatment in first-episode schizophrenia publication-title: Am J Psychiatry contributor: fullname: Tiihonen, J – volume: 75 start-page: 555 year: 2018 end-page: 565 article-title: Comparison of early intervention services vs treatment as usual for early-phase psychosis: a systematic review, meta-analysis, and meta-regression publication-title: JAMA Psychiatry contributor: fullname: Galling, B – volume: 197 start-page: 350 year: 2010 end-page: 356 article-title: Early intervention services, cognitive-behavioural therapy and family intervention in early psychosis: systematic review publication-title: Br J Psychiatry contributor: fullname: Premkumar, P – volume: 37 start-page: 619 year: 2011 end-page: 630 article-title: Preventing the second episode: a systematic review and meta-analysis of psychosocial and pharmacological trials in first-episode psychosis publication-title: Schizophr Bull contributor: fullname: Parker, AG – volume: 66 start-page: 680 year: 2015 end-page: 690 article-title: The NAVIGATE program for first-episode psychosis: rationale, overview, and description of psychosocial components publication-title: Psychiatr Serv contributor: fullname: Addington, J – volume: 36 start-page: 71 year: 2010 end-page: 93 article-title: The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements publication-title: Schizophr Bull contributor: fullname: Buchanan, RW – volume: 21 start-page: 29 year: 2006 end-page: 33 article-title: A prospective evaluation of adherence to medication in first episode schizophrenia publication-title: Eur Psychiatry contributor: fullname: Clarke, M – volume: 196 start-page: 866 year: 2009 end-page: 875 article-title: Group cognitive behavioral therapy or social skills training for individuals with a recent onset of psychosis: results of a randomized controlled trial publication-title: J Nerv Ment Dis contributor: fullname: Leclerc, C – volume: 36 start-page: 732 year: 2010 end-page: 739 article-title: The appropriateness of routine medication treatment for schizophrenia publication-title: Schizophr Bull contributor: fullname: Cohen, AN – volume: 21 start-page: 29 year: 2006 end-page: 33 article-title: A prospective evaluation of adherence to medication in first episode schizophrenia publication-title: Eur Psychiatry contributor: fullname: Kelly, BD – volume: 74 start-page: 686 year: 2017 end-page: 693 article-title: Real-world effectiveness of anti-psychotic treatments in a nationwide cohort of 29,823 patients with schizophrenia publication-title: JAMA Psychiatry contributor: fullname: Majak, M – volume: 42 start-page: 896 year: 2016 end-page: 906 article-title: Cost-effectiveness of comprehensive, integrated care for first episode psychosis in the NIMH RAISE early treatment program publication-title: Schizophr Bull contributor: fullname: Sint, K – volume: 175 start-page: 765 year: 2018 end-page: 773 article-title: 20-year nationwide follow-up study on discontinuation of antipsychotic treatment in first-episode schizophrenia publication-title: Am J Psychiatry contributor: fullname: Tanskanen, A – volume: 56 start-page: 241 year: 1999 end-page: 247 article-title: Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder publication-title: Arch Gen Psychiatry contributor: fullname: Robinson, D – volume: 24 start-page: 11 year: 1998 end-page: 32 article-title: Patterns of usual care for schizophrenia: initial results from the Schizophrenia Patient Outcomes Research Team (PORT) Client Survey publication-title: Schizophr Bull contributor: fullname: Lehman, AF – volume: 56 start-page: 241 year: 1999 end-page: 247 article-title: Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder publication-title: Arch Gen Psychiatry contributor: fullname: Woerner, MG – volume: 196 start-page: 866 year: 2009 end-page: 875 article-title: Group cognitive behavioral therapy or social skills training for individuals with a recent onset of psychosis: results of a randomized controlled trial publication-title: J Nerv Ment Dis contributor: fullname: Lecomte, T – volume: 173 start-page: 362 year: 2016 end-page: 372 article-title: Comprehensive versus usual community care for first-episode psychosis: 2-year outcomes from the NIMH RAISE early treatment program publication-title: Am J Psychiatry contributor: fullname: Robinson, DG – volume: 37 start-page: 619 year: 2011 end-page: 630 article-title: Preventing the second episode: a systematic review and meta-analysis of psychosocial and pharmacological trials in first-episode psychosis publication-title: Schizophr Bull contributor: fullname: Alvarez-Jiménez, M – volume: 367 start-page: 2006 year: 2012 end-page: 2014 article-title: Medication for attention deficit-hyperactivity disorder and criminality publication-title: N Engl J Med contributor: fullname: Halldner, L – volume: 367 start-page: 2006 year: 2012 end-page: 2014 article-title: Medication for attention deficit-hyperactivity disorder and criminality publication-title: N Engl J Med contributor: fullname: Zetterqvist, J – volume: 76 start-page: 240 year: 2015 end-page: 246 article-title: The RAISE Early Treatment Program for first-episode psychosis: background, rationale, and study design publication-title: J Clin Psychiatry contributor: fullname: Schooler, NR – volume: 172 start-page: 237 year: 2015 end-page: 248 article-title: Prescription practices in the treatment of first-episode schizophrenia spectrum disorders: data from the national RAISE-ETP study publication-title: Am J Psychiatry contributor: fullname: Schooler, NR – volume: 24 start-page: 11 year: 1998 end-page: 32 article-title: Patterns of usual care for schizophrenia: initial results from the Schizophrenia Patient Outcomes Research Team (PORT) Client Survey publication-title: Schizophr Bull contributor: fullname: Steinwachs, DM – volume: 65 start-page: 121 year: 2014 end-page: 124 article-title: State and demographic variation in use of depot antipsychotics by Medicaid beneficiaries with schizophrenia publication-title: Psychiatr Serv contributor: fullname: Caffery, E – volume: 73 start-page: 721 year: 2016 end-page: 730 article-title: Metabolic testing for adults in a state Medicaid program receiving antipsychotics: remaining barriers to achieving population health goals publication-title: JAMA Psychiatry contributor: fullname: Brewer, SE – volume: 72 start-page: 822 year: 2015 end-page: 829 article-title: Long-acting injectable risperidone for relapse prevention and control of breakthrough symptoms after a recent first episode of schizophrenia: a randomized clinical trial publication-title: JAMA Psychiatry contributor: fullname: Casaus, LR – volume: 367 start-page: 2006 year: 2012 end-page: 2014 article-title: Medication for attention deficit-hyperactivity disorder and criminality publication-title: N Engl J Med contributor: fullname: Lichtenstein, P – volume: 73 start-page: 498 year: 2012 end-page: 503 article-title: The impact of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) on prescribing practices: an analysis of data from a large midwestern state publication-title: J Clin Psychiatry contributor: fullname: Patel, U – volume: 75 start-page: 555 year: 2018 end-page: 565 article-title: Comparison of early intervention services vs treatment as usual for early-phase psychosis: a systematic review, meta-analysis, and meta-regression publication-title: JAMA Psychiatry contributor: fullname: Pawar, A – volume: 36 start-page: 71 year: 2010 end-page: 93 article-title: The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements publication-title: Schizophr Bull contributor: fullname: Kelly, DL – volume: 73 start-page: 721 year: 2016 end-page: 730 article-title: Metabolic testing for adults in a state Medicaid program receiving antipsychotics: remaining barriers to achieving population health goals publication-title: JAMA Psychiatry contributor: fullname: Campagna, EJ – volume: 65 start-page: 121 year: 2014 end-page: 124 article-title: State and demographic variation in use of depot antipsychotics by Medicaid beneficiaries with schizophrenia publication-title: Psychiatr Serv contributor: fullname: Barrett, A – volume: 42 start-page: 896 year: 2016 end-page: 906 article-title: Cost-effectiveness of comprehensive, integrated care for first episode psychosis in the NIMH RAISE early treatment program publication-title: Schizophr Bull contributor: fullname: Rosenheck, R – volume: 170 start-page: 311 year: 2016 end-page: 317 article-title: Substance use, medication adherence and outcome one year following a first episode of psychosis publication-title: Schizophr Res contributor: fullname: Colizzi, M – volume: 73 start-page: 498 year: 2012 end-page: 503 article-title: The impact of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) on prescribing practices: an analysis of data from a large midwestern state publication-title: J Clin Psychiatry contributor: fullname: Berkowitz, RL – volume: 172 start-page: 237 year: 2015 end-page: 248 article-title: Prescription practices in the treatment of first-episode schizophrenia spectrum disorders: data from the national RAISE-ETP study publication-title: Am J Psychiatry contributor: fullname: John, M – volume: 36 start-page: 71 year: 2010 end-page: 93 article-title: The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements publication-title: Schizophr Bull contributor: fullname: Kreyenbuhl, J – volume: 73 start-page: 721 year: 2016 end-page: 730 article-title: Metabolic testing for adults in a state Medicaid program receiving antipsychotics: remaining barriers to achieving population health goals publication-title: JAMA Psychiatry contributor: fullname: Morrato, EH – volume: 66 start-page: 680 year: 2015 end-page: 690 article-title: The NAVIGATE program for first-episode psychosis: rationale, overview, and description of psychosocial components publication-title: Psychiatr Serv contributor: fullname: Mueser, KT – volume: 264 start-page: 151 year: 2018 end-page: 154 article-title: Non-adherence to antipsychotic medication in first-episode psychosis patients publication-title: Psychiatry Res contributor: fullname: Hickling, LM – volume: 72 start-page: 822 year: 2015 end-page: 829 article-title: Long-acting injectable risperidone for relapse prevention and control of breakthrough symptoms after a recent first episode of schizophrenia: a randomized clinical trial publication-title: JAMA Psychiatry contributor: fullname: Subotnik, KL – volume: 76 start-page: 240 year: 2015 end-page: 246 article-title: The RAISE Early Treatment Program for first-episode psychosis: background, rationale, and study design publication-title: J Clin Psychiatry contributor: fullname: Kane, JM – volume: 168 start-page: 603 year: 2011 end-page: 609 article-title: A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia publication-title: Am J Psychiatry contributor: fullname: Taylor, M – volume: 264 start-page: 151 year: 2018 end-page: 154 article-title: Non-adherence to antipsychotic medication in first-episode psychosis patients publication-title: Psychiatry Res contributor: fullname: Nterian, Z – volume: 75 start-page: 555 year: 2018 end-page: 565 article-title: Comparison of early intervention services vs treatment as usual for early-phase psychosis: a systematic review, meta-analysis, and meta-regression publication-title: JAMA Psychiatry contributor: fullname: Correll, CU – volume: 74 start-page: 686 year: 2017 end-page: 693 article-title: Real-world effectiveness of anti-psychotic treatments in a nationwide cohort of 29,823 patients with schizophrenia publication-title: JAMA Psychiatry contributor: fullname: Mittendorfer-Rutz, E – volume: 172 start-page: 237 year: 2015 end-page: 248 article-title: Prescription practices in the treatment of first-episode schizophrenia spectrum disorders: data from the national RAISE-ETP study publication-title: Am J Psychiatry contributor: fullname: Robinson, DG – volume: 173 start-page: 362 year: 2016 end-page: 372 article-title: Comprehensive versus usual community care for first-episode psychosis: 2-year outcomes from the NIMH RAISE early treatment program publication-title: Am J Psychiatry contributor: fullname: Schooler, NR – volume: 76 start-page: 240 year: 2015 end-page: 246 article-title: The RAISE Early Treatment Program for first-episode psychosis: background, rationale, and study design publication-title: J Clin Psychiatry contributor: fullname: Marcy, P – volume: 42 start-page: 896 year: 2016 end-page: 906 article-title: Cost-effectiveness of comprehensive, integrated care for first episode psychosis in the NIMH RAISE early treatment program publication-title: Schizophr Bull contributor: fullname: Leslie, D – volume: 74 start-page: 686 year: 2017 end-page: 693 article-title: Real-world effectiveness of anti-psychotic treatments in a nationwide cohort of 29,823 patients with schizophrenia publication-title: JAMA Psychiatry contributor: fullname: Tiihonen, J – volume: 196 start-page: 866 year: 2009 end-page: 875 article-title: Group cognitive behavioral therapy or social skills training for individuals with a recent onset of psychosis: results of a randomized controlled trial publication-title: J Nerv Ment Dis contributor: fullname: Corbiere, M – volume: 197 start-page: 350 year: 2010 end-page: 356 article-title: Early intervention services, cognitive-behavioural therapy and family intervention in early psychosis: systematic review publication-title: Br J Psychiatry contributor: fullname: Kendall, T – volume: 173 start-page: 362 year: 2016 end-page: 372 article-title: Comprehensive versus usual community care for first-episode psychosis: 2-year outcomes from the NIMH RAISE early treatment program publication-title: Am J Psychiatry contributor: fullname: Kane, JM – volume: 46 start-page: 91 year: 2020 end-page: 97 article-title: Service use following first-episode schizophrenia among commercially insured youth publication-title: Schizophr Bull contributor: fullname: Susser, E – volume: 175 start-page: 765 year: 2018 end-page: 773 article-title: 20-year nationwide follow-up study on discontinuation of antipsychotic treatment in first-episode schizophrenia publication-title: Am J Psychiatry contributor: fullname: Taipale, H – volume: 21 start-page: 29 year: 2006 end-page: 33 article-title: A prospective evaluation of adherence to medication in first episode schizophrenia publication-title: Eur Psychiatry contributor: fullname: Kamali, M – volume: 46 start-page: 91 year: 2020 end-page: 97 article-title: Service use following first-episode schizophrenia among commercially insured youth publication-title: Schizophr Bull contributor: fullname: van der Ven, E – volume: 72 start-page: 822 year: 2015 end-page: 829 article-title: Long-acting injectable risperidone for relapse prevention and control of breakthrough symptoms after a recent first episode of schizophrenia: a randomized clinical trial publication-title: JAMA Psychiatry contributor: fullname: Ventura, J – volume: 168 start-page: 603 year: 2011 end-page: 609 article-title: A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia publication-title: Am J Psychiatry contributor: fullname: Tiihonen, J – volume: 36 start-page: 732 year: 2010 end-page: 739 article-title: The appropriateness of routine medication treatment for schizophrenia publication-title: Schizophr Bull contributor: fullname: Niv, N – volume: 282 start-page: 1458 year: 1999 end-page: 1465 article-title: Why don’t physicians follow clinical practice guidelines? A framework for improvement publication-title: JAMA contributor: fullname: Rand, CS – volume: 170 start-page: 311 year: 2016 end-page: 317 article-title: Substance use, medication adherence and outcome one year following a first episode of psychosis publication-title: Schizophr Res contributor: fullname: Fraietta, S – volume: 66 start-page: 680 year: 2015 end-page: 690 article-title: The NAVIGATE program for first-episode psychosis: rationale, overview, and description of psychosocial components publication-title: Psychiatr Serv contributor: fullname: Penn, DL – volume: 197 start-page: 350 year: 2010 end-page: 356 article-title: Early intervention services, cognitive-behavioural therapy and family intervention in early psychosis: systematic review publication-title: Br J Psychiatry contributor: fullname: Bird, V – ident: B12 – ident: B16 doi: 10.1176/appi.ajp.2011.10081224 – ident: B20 doi: 10.1176/appi.ps.201300001 – ident: B1 doi: 10.1093/schbul/sbp129 – ident: B5 doi: 10.4088/JCP.10m06497 – ident: B25 doi: 10.2337/diacare.27.2.596 – ident: B18 doi: 10.1016/j.psychres.2018.04.002 – ident: B8 doi: 10.1093/oxfordjournals.schbul.a033303 – ident: B26 doi: 10.1001/jamapsychiatry.2016.0538 – ident: B4 doi: 10.1001/jamapsychiatry.2018.0623 – ident: B10 doi: 10.1176/appi.ajp.2014.13101355 – ident: B2 doi: 10.1192/bjp.bp.109.074526 – ident: B3 doi: 10.1176/appi.ajp.2015.15050632 – ident: B21 doi: 10.1001/archpsyc.56.3.241 – ident: B6 doi: 10.4088/JCP.14m09289 – ident: B17 doi: 10.1016/j.eurpsy.2005.05.015 – ident: B28 doi: 10.1093/schbul/sbv224 – ident: B19 doi: 10.1016/j.schres.2015.11.016 – ident: B22 doi: 10.1176/appi.ajp.2018.17091001 – volume: 46 start-page: 91 year: 2020 ident: B11 publication-title: Schizophr Bull contributor: fullname: Gilmer TP – ident: B24 doi: 10.1093/schbul/sbp116 – ident: B13 doi: 10.1176/appi.ps.201400413 – ident: B23 doi: 10.1001/jamapsychiatry.2015.0270 – ident: B27 doi: 10.1097/NMD.0b013e31818ee231 – ident: B9 doi: 10.1001/jama.282.15.1458 – ident: B15 doi: 10.1056/NEJMoa1203241 – ident: B14 doi: 10.1001/jamapsychiatry.2017.1322 – ident: B7 doi: 10.1093/schbul/sbn138 |
SSID | ssj0001716 |
Score | 2.4188735 |
Snippet | Objective:Coordinated specialty care (CSC) has become the standard of care for first-episode psychosis (FEP). The gap between CSC best practices and the actual... Coordinated specialty care (CSC) has become the standard of care for first-episode psychosis (FEP). The gap between CSC best practices and the actual care... Objective: Coordinated specialty care (CSC) has become the standard of care for first-episode psychosis (FEP). The gap between CSC best practices and the... OBJECTIVECoordinated specialty care (CSC) has become the standard of care for first-episode psychosis (FEP). The gap between CSC best practices and the actual... |
SourceID | proquest crossref pubmed appi |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 247 |
SubjectTerms | Antipsychotics Best practice Health services utilization Medicaid Psychosis Quality of care |
Title | Using Claims Data to Assess Treatment Quality of First-Episode Psychosis |
URI | http://dx.doi.org/10.1176/appi.ps.201900595 https://www.ncbi.nlm.nih.gov/pubmed/33167819 https://www.proquest.com/docview/2511377864 https://search.proquest.com/docview/2459346903 |
Volume | 72 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3da9swEBdp9zIYo_ts2m5oMBisOEss-euxpA4ZK93o3NE9GVmSwZDF3pz8_72z5I8SWraHvRgjG9nofjr97nR3IuQ954IxrmCm-Vo7PFTcESqPHBZpOZMhHjKCruzl9-DyJjyPeTwatQeT9G3_VdLQBrLGzNl_kHbXKTTAPcgcriB1uP6V3E0MwHwlil81yHQjkF2ard3TpIsqN6Uzmt31RQEE0Imroi6VtgqxLuoha_3WhkQX8rS2ygWpaXcSk1Fdk_lk4Fi40oXJJxnUL2if_RArZRMhVkW_PXRldOBP6PP3ALa9B-EssxH-1k_hDgK1BqkBrWK3v9y72nYiP8EsxWQ5u2mjrXb2AicKptOh-g7cAUzZUBebUp67a0TQFEeuqmJSYcF2oETAMb1-QWyDAC6_povri4s0iW-SPfLIBVXWGO2fv3RrPRYbMlGt5mftvjl84tPOB2DRx7a7BOgeq6ZhN8kBeWrNEnpm8PSMjPT6OXlifLrUpKq9IMsGW9RgiyK26KakBlu0wxa12KJlTu9gi3bYekmuF3EyXzr2JA5HMD_cOLNQySlQVSyWmDGY1iyTbihzAQwyUqDGde67ioWZRHM1Z9LHcwG0p6T2piIT7BXZX5drfUioH4Uq8_hMyybEOI8EczWQdBWidcuCMfmAo5TaKVWnjZUa-GnTWtVpN55j8rEdyLQypVkeevmkHeq-azSvGRZQ5GPyrnsM-hU3zcRal1t4h3sRQx8SG5PXRkTd1xiWkQBKffRw58fkcT8hTsj-5s9WvyF7tdq-bdB0C3KjnT4 |
link.rule.ids | 315,782,786,27933,27934 |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Using+Claims+Data+to+Assess+Treatment+Quality+of+First-Episode+Psychosis&rft.jtitle=Psychiatric+services+%28Washington%2C+D.C.%29&rft.au=Reist%2C+Christopher&rft.au=Valdes%2C+Elise&rft.au=Ren%2C+Yingqian&rft.au=Wright%2C+Abel&rft.date=2021-03-01&rft.pub=American+Psychiatric+Publishing%2C+Inc&rft.issn=1075-2730&rft.eissn=1557-9700&rft.volume=72&rft.issue=3&rft.spage=247&rft_id=info:doi/10.1176%2Fappi.ps.201900595&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1075-2730&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1075-2730&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1075-2730&client=summon |